Status:
COMPLETED
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
Lead Sponsor:
UMC Utrecht
Conditions:
Cervix Neoplasms
Ovarian Neoplasms
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of the study is to determine the diagnostic accuracy of a new magnetic resonance imaging (MRI) technique, the diffusion weighted imaging with body background signal suppression (DWIBS) in ...
Detailed Description
The presence of lymph node metastases indicates a poor prognosis, with a marked decrease in 5-year survival rate. Lymph node involvement is an important factor in the choice of adjuvant treatment in g...
Eligibility Criteria
Inclusion
- Patients with
- Cervical cancer stage Ia2-Ib, IIa
- Endometrial cancer stage I (high risk), II
- Ovarian cancer stage I, IIa-IIa
- Vulvar cancer stage I, II
- Age \> 18 years
- Karnofsky score \> 70
Exclusion
- Eligible for the PORTEC II trial
- Contra-indications to the MRI: surgical clips in the brain, a pacemaker and claustrophobia
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00288821
Start Date
February 1 2006
End Date
March 1 2009
Last Update
February 9 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Utrecht
Utrecht, Pb 85500, Netherlands, 3508 GA